Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Europe defibrillators market has the potential to reach $ 4,467.4 million by 2022. The defibrillators market is primarily driven due to the growing adoption of technologically advanced defibrillators, increasing demand for quality medical care, high incidences of SCA and cardiovascular diseases. Also, the increasing interest from public & private organizations and key market players for public access defibrillators and a growing number of programs that raise awareness about the effectiveness of defibrillators are other factors fueling the growth of the market.
The report highlights the adoption of Defibrillators in Europe. Based on the product type; the Defibrillators market is segmented into Advanced Life Support (ALS) Defibrillators, Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICD), Wearable Defibrillators market. Further the Implantable Cardioverter Defibrillators (ICD) segment is sub segmented into Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) market. Based on the end use avenue, the market is bifurcated into Hospitals, Pre-hospitals, Public Access Markets, Alternate Care Markets, Home Healthcare market.
The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe. The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.